Search hospitals > Minnesota > Minneapolis
University of Minnesota/Masonic Cancer Center
Claim this profileMinneapolis, Minnesota 55455
Global Leader in Cancer
Global Leader in Leukemia
Conducts research for Lymphoma
Conducts research for Solid Tumors
Conducts research for Acute Myelogenous Leukemia
723 reported clinical trials
35 medical researchers
Summary
University of Minnesota/Masonic Cancer Center is a medical facility located in Minneapolis, Minnesota. This center is recognized for care of Cancer, Leukemia, Lymphoma, Solid Tumors, Acute Myelogenous Leukemia and other specialties. University of Minnesota/Masonic Cancer Center is involved with conducting 723 clinical trials across 720 conditions. There are 35 research doctors associated with this hospital, such as Emily Greengard, Manish Patel, Christopher Moertel, and Peter M. Gordon.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Leukemia
Global LeaderStage II
Stage I
NTRK1 positive
Top PIs
Emily GreengardUniversity of Minnesota/Masonic Cancer Center5 years of reported clinical research
Expert in Cancer
Expert in Neuroblastoma
46 reported clinical trials
74 drugs studied
Manish PatelFlorida Cancer Specialists2 years of reported clinical research
Expert in Solid Tumors
Expert in Cancer
31 reported clinical trials
49 drugs studied
Christopher MoertelUniversity of Minnesota/Masonic Cancer Center5 years of reported clinical research
Studies Neurofibromatosis
Studies Brain Tumor
15 reported clinical trials
24 drugs studied
Peter M. GordonUniversity of Minnesota/Masonic Cancer Center6 years of reported clinical research
Studies Burkitt Lymphoma
Studies Acute Lymphoblastic Leukemia
13 reported clinical trials
39 drugs studied
Clinical Trials running at University of Minnesota/Masonic Cancer Center
Skin Cancer
Ovarian Cancer
Acute Lymphoblastic Leukemia
Myelodysplastic Syndrome
Cancer
Acute Myeloid Leukemia
Leukemia
Acute Myelogenous Leukemia
Neuroblastoma
Follicular Lymphoma
Cemiplimab + Surgery
for Advanced Skin Cancer
This phase III trial compares the effect of adding cemiplimab to standard therapy (surgery with or without radiation) versus standard therapy alone in treating patients with stage III/IV squamous cell skin cancer that is able to be removed by surgery (resectable) and that may have come back after a period of improvement (recurrent). The usual treatment for patients with resectable squamous cell skin cancer is the removal of the cancerous tissue (surgery) with or without radiation, which uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Immunotherapy with monoclonal antibodies, such as cemiplimab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cemiplimab has been approved for the treatment of skin cancer that has spread or that cannot be removed by surgery, but it has not been approved for the treatment of skin cancer than can be removed by surgery. Adding cemiplimab to the usual treatment of surgery with or without radiation may be more effective in treating patients with stage III/IV resectable squamous cell skin cancer than the usual treatment alone.
Recruiting2 awards Phase 37 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of Minnesota/Masonic Cancer Center?
University of Minnesota/Masonic Cancer Center is a medical facility located in Minneapolis, Minnesota. This center is recognized for care of Cancer, Leukemia, Lymphoma, Solid Tumors, Acute Myelogenous Leukemia and other specialties. University of Minnesota/Masonic Cancer Center is involved with conducting 723 clinical trials across 720 conditions. There are 35 research doctors associated with this hospital, such as Emily Greengard, Manish Patel, Christopher Moertel, and Peter M. Gordon.
Where is University of Minnesota/Masonic Cancer Center located?
**Masonic Cancer Center, University of Minnesota Health Clinics and Surgery Center**
- **Location:** 425 E River Pkwy, Minneapolis, MN 55455.
- **Directions:** From I-35W south, take Highway 280 south to I-94W, then continue to Huron Boulevard.
- **City:** Minneapolis, MN.
Who should I call to ask about financial aid or insurance network?
The University of Minnesota/Masonic Cancer Center offers several contact options for financial assistance and insurance queries:
- For general payment inquiries, contact the Community-University Health Care Center (CUHCC) at 612-301-3433.
- For cancer-related insurance guidance, reach out to the Masonic Cancer Clinic's Cancer Information Nurse Line at 612-624-2620.
- To schedule appointments, call 612-676-4200, and for hematology and oncology services referrals, contact M Health Fairview Cancer Care at 855-486-7226.
What insurance does University of Minnesota/Masonic Cancer Center accept?
The University of Minnesota Physicians encourage patients to understand their insurance coverage, benefits, and out-of-pocket costs before visiting. For detailed information on accepted insurance plans, contact the University of Minnesota/Masonic Cancer Center directly or visit their official website.
What awards or recognition has University of Minnesota/Masonic Cancer Center received?
The Masonic Cancer Center at the University of Minnesota, located in Minneapolis, Minnesota, is a National Cancer Institute-designated comprehensive cancer center since 1998. It is recognized for its outstanding research and care. The center has also been awarded a $5.1 million grant by the National Institute of Environmental Health Sciences to research the impact of environmental factors on cancer.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.